The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Free cash flow
The Cooper Companies, Inc.'s free cash flow for fiscal 2025 was $433.7M, up 50.5% from $288.1M in fiscal 2024. Over the twelve months to 31 July 2026 it was $678.0M. Over the past ten years it has ranged from $147.9M (fiscal 2015) to $524.2M (fiscal 2021); the current reading is higher than 64% of that period. The Cooper Companies, Inc. ranks 7th of 54 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $433.7M | 50.54% |
| FY2024 | $288.1M | 34.00% |
| FY2023 | $215.0M | (52.26%) |
| FY2022 | $450.4M | (14.08%) |
| FY2021 | $524.2M | 197.50% |
| FY2020 | $176.2M | (58.16%) |
| FY2019 | $421.1M | (11.40%) |
| FY2018 | $475.3M | 1.91% |
| FY2017 | $466.4M | 30.64% |
| FY2016 | $357.0M | 141.38% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jul 2026 | $273.0M | 183.20% |
| Apr 2026 | $96.4M | (39.26%) |
| Jan 2026 | $158.7M | 5.87% |
| Oct 2025 | $149.9M | (8.88%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BAX Baxter International Inc. compare | $815.0M |
| COO The Cooper Companies, Inc. | $678.0M |
| ALGN Align Technology, Inc. compare | $675.6M |
| AVTR Avantor, Inc. compare | $454.7M |
| ATR AptarGroup, Inc. compare | $314.6M |
| TFX Teleflex Incorporated compare | $168.4M |
| BLCO Bausch + Lomb Corporation compare | $137.0M |
| RGEN Repligen Corporation compare | $110.3M |
| SOLV Solventum Corporation compare | −$118.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement